153 related articles for article (PubMed ID: 21234288)
41. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies.
Wilson RD; ; Wilson RD; Audibert F; Brock JA; Carroll J; Cartier L; Gagnon A; Johnson JA; Langlois S; Murphy-Kaulbeck L; Okun N; Pastuck M; ; Deb-Rinker P; Dodds L; Leon JA; Lowel HL; Luo W; MacFarlane A; McMillan R; Moore A; Mundle W; O'Connor D; Ray J; Van den Hof M
J Obstet Gynaecol Can; 2015 Jun; 37(6):534-52. PubMed ID: 26334606
[TBL] [Abstract][Full Text] [Related]
42. An incident case-referent study on plasma enterolactone and breast cancer risk.
Hultén K; Winkvist A; Lenner P; Johansson R; Adlercreutz H; Hallmans G
Eur J Nutr; 2002 Aug; 41(4):168-76. PubMed ID: 12242585
[TBL] [Abstract][Full Text] [Related]
43. Effects of a flaxseed-derived lignan supplement on C-reactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients.
Pan A; Demark-Wahnefried W; Ye X; Yu Z; Li H; Qi Q; Sun J; Chen Y; Chen X; Liu Y; Lin X
Br J Nutr; 2009 Apr; 101(8):1145-9. PubMed ID: 18775100
[TBL] [Abstract][Full Text] [Related]
44. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
Barba M; Yang L; Schünemann HJ; Sperati F; Grioni S; Stranges S; Westerlind KC; Blandino G; Gallucci M; Lauria R; Malorni L; Muti P
J Exp Clin Cancer Res; 2009 Oct; 28(1):135. PubMed ID: 19814782
[TBL] [Abstract][Full Text] [Related]
45. Altered estrogen metabolism and excretion in humans following consumption of indole-3-carbinol.
Michnovicz JJ; Bradlow HL
Nutr Cancer; 1991; 16(1):59-66. PubMed ID: 1656396
[TBL] [Abstract][Full Text] [Related]
46. A randomized controlled clinical trial investigating the effect of calcium supplement plus low-dose aspirin on hs-CRP, oxidative stress and insulin resistance in pregnant women at risk for pre-eclampsia.
Asemi Z; Samimi M; Heidarzadeh Z; Khorrammian H; Tabassi Z
Pak J Biol Sci; 2012 May; 15(10):469-76. PubMed ID: 24187901
[TBL] [Abstract][Full Text] [Related]
47. Alterations in estradiol metabolism in MCF-7 cells induced by treatment with indole-3-carbinol and related compounds.
Niwa T; Swaneck G; Bradlow HL
Steroids; 1994 Sep; 59(9):523-7. PubMed ID: 7846734
[TBL] [Abstract][Full Text] [Related]
48. Multi-nutrient supplement improves hormone ratio associated with cancer risk.
Bazzan AJ; Zabrecky GP; Newberg AB
J Transl Med; 2013 Oct; 11():252. PubMed ID: 24103703
[TBL] [Abstract][Full Text] [Related]
49. Serum isoflavones and lignans and odds of breast cancer in pre- and postmenopausal Chinese women.
Feng XL; Ho SC; Zhan XX; Zuo LS; Mo XF; Zhang X; Abulimiti A; Huang CY; Zhang CX
Menopause; 2021 Jan; 28(4):413-422. PubMed ID: 33399319
[TBL] [Abstract][Full Text] [Related]
50. Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.
Basaria S; Wisniewski A; Dupree K; Bruno T; Song MY; Yao F; Ojumu A; John M; Dobs AS
J Endocrinol Invest; 2009 Feb; 32(2):150-5. PubMed ID: 19411814
[TBL] [Abstract][Full Text] [Related]
51. Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancer.
Bradlow HL; Sepkovic DW; Telang N; Tiwari R
In Vivo; 2011; 25(4):585-8. PubMed ID: 21709000
[TBL] [Abstract][Full Text] [Related]
52. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.
Hofmeyr GJ; Manyame S
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421
[TBL] [Abstract][Full Text] [Related]
53. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Hammerstein J; Daume E; Simon A; Winkler UH; Schindler AE; Back DJ; Ward S; Neiss A
Contraception; 1993 Mar; 47(3):263-81. PubMed ID: 8462317
[TBL] [Abstract][Full Text] [Related]
54. Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Ho GH; Luo XW; Ji CY; Foo SC; Ng EH
Ann Acad Med Singap; 1998 Mar; 27(2):294-9. PubMed ID: 9663330
[TBL] [Abstract][Full Text] [Related]
55. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
[TBL] [Abstract][Full Text] [Related]
56. Mammographic Density and Vitamin D Levels - A Cross-sectional Study.
Straub L; Riedel J; Luppa PB; Wissing J; Artmann A; Kiechle M; Seifert-Klauss VR
Geburtshilfe Frauenheilkd; 2017 Mar; 77(3):257-267. PubMed ID: 28392579
[No Abstract] [Full Text] [Related]
57. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
58. Effect of dietary soy isoflavone aglycones on the urinary 16alpha-to-2-hydroxyestrone ratio in C3H/HeJ mice.
Kishida T; Beppu M; Nashiki K; Izumi T; Ebihara K
Nutr Cancer; 2000; 38(2):209-14. PubMed ID: 11525599
[TBL] [Abstract][Full Text] [Related]
59. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
